{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T03:59:34Z","timestamp":1777089574148,"version":"3.51.4"},"reference-count":40,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2008,1,21]],"date-time":"2008-01-21T00:00:00Z","timestamp":1200873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2008,7]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>\n<jats:list list-type=\"explicit-label\">\n<jats:list-item><jats:p>Propofol is an anti\u2010inflammatory agent commonly used for general anaesthesia and sedation in intensive care unit patients. Haemorrhagic shock (HS) followed by resuscitation can induce the production of several inflammatory mediators, such as tumour necrosis factor (TNF)\u2010a and interleukin (IL)\u201010, leading to multiple organ dysfunction and death.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>In the present study, we investigated the effects of treatment with high\u2010dose (10\u00a0mg\/kg per h) and low\u2010dose (1\u00a0mg\/kg per h) propofol after HS on the physiopathology and cytokine levels in conscious rats.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>The experiments were designed to induce HS by withdrawing 40% of total blood volume from a femoral artery catheter (6\u00a0mL\/100\u00a0g bodyweight) over 30\u00a0min. Mean arterial pressure (MAP) and heart rate (HR) were monitored continuously for 48\u00a0h after the start of blood withdrawal. Levels of biochemical parameters, including glutamic oxaloacetic transaminase (GOT), glutamic pyruvic transaminase (GPT), blood urea nitrogen (BUN), creatinine, creatine phosphokinase (CPK) and lactate dehydrogenase (LDH), were measured 30\u00a0min before and 0, 1, 3, 6, 9, 12, 18, 24 and 48\u00a0h after the end of the 30\u00a0min blood withdrawal period. Serum cytokine levels, including TNF\u2010a and IL\u201010, were measured at 1, 6, 12, 24 and 48\u00a0h after HS. The kidneys, liver, lungs and small intestine were removed for pathological assessment 48\u00a0h after HS.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>In the present study, HS significantly increased blood GOT, GPT, BUN, LDH, CPK, TNF\u2010a and IL\u201010 levels in conscious rats. Post\u2010treatment with high\u2010dose propofol accentuated systemic hypotension, increased serum TNF\u2010a and IL\u201010 levels and increased the severity of organ damage after HS. In contrast, post\u2010treatment with low\u2010dose propofol did not affect MAP, but did suppress increased serum levels of the inflammatory cytokines and improved the survival rate after HS, thus protecting rats against HS\u2010induced organ damage.<\/jats:p><\/jats:list-item>\n<jats:list-item><jats:p>In conclusion, post\u2010treatment with low\u2010dose propofol ameliorated HS\u2010induced markers of organ injury, suppressed the release of TNF\u2010a and IL\u201010 and protected against HS\u2010induced liver, kidney, lung and small intestine damage in conscious rats. These findings suggest the need to investigate whether low\u2010dose propofol may be beneficial for patients with HS\u2010induced organ damage.<\/jats:p><\/jats:list-item>\n<\/jats:list>\n<\/jats:p>","DOI":"10.1111\/j.1440-1681.2007.04859.x","type":"journal-article","created":{"date-parts":[[2008,2,29]],"date-time":"2008-02-29T03:12:55Z","timestamp":1204254775000},"page":"766-774","source":"Crossref","is-referenced-by-count":15,"title":["LOW\u2010DOSE PROPOFOL AMELIORATES HAEMORRHAGIC SHOCK\u2010INDUCED ORGAN DAMAGE IN CONSCIOUS RATS"],"prefix":"10.1111","volume":"35","author":[{"given":"Chung\u2010Jen","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi\u2010Maun","family":"Subeq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru\u2010Ping","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen\u2010Tien","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bang\u2010Gee","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,1,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ta.0000199961.02677.19"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2004.12.037"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ta.0000224211.36154.44"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90770-8"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199550030-00008"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199909000-00023"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-199809000-00039"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200204000-00032"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2005.04155.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2006.06.040"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11373-005-9065-3"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2006.05.031"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ta.0000197417.03460.0a"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc2851"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-199402000-00010"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000114815.88622.9D"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-199904000-00004"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.158.2.9710092"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005373-199806000-00016"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199508000-00004"},{"key":"e_1_2_6_22_2","first-page":"H2219","article-title":"Significance of TNF in hemorrhage\u2010related hemodynamic alterations, organ injury, and mortality in rats","volume":"272","author":"Bahrami S","year":"1997","journal-title":"Am. J. Physiol"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1006\/jsre.2000.5860"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200201001-00008"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.3109\/08923979609052737"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199811000-00012"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(94)01337-Z"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000198530.68343.21"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200004000-00032"},{"key":"e_1_2_6_30_2","first-page":"1203","article-title":"Effect of propofol on protecting Rhesus macaques from reperfusion lung injury during hemorrhagic shock and resuscitation","volume":"82","author":"Song Q","year":"2002","journal-title":"Chin. Med. J"},{"key":"e_1_2_6_31_2","first-page":"333","article-title":"Cardiocirculatory effects of intravenous anesthetic induction in an experimental model of acute hypovolemia","volume":"45","author":"Errando CL","year":"1998","journal-title":"Rev. Esp. Anestesiol. Reanim"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200409000-00013"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200308000-00023"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000242326.01745.13"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000050627.90734.ED"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.shk.0000209539.91553.82"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/35013070"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200405000-00023"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-6576.2003.00228.x"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.90.4.523"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccx.0000144771.96342.2c"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.2007.04859.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.2007.04859.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T10:49:44Z","timestamp":1696934984000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1681.2007.04859.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,21]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["10.1111\/j.1440-1681.2007.04859.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1681.2007.04859.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,21]]}}}